MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 195 filers reported holding MEDICINES CO in Q3 2018. The put-call ratio across all filers is 1.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,000 | +100.0% | 173 | +33.1% | 0.00% | +100.0% |
| Q2 2019 | $4,000 | -77.8% | 130 | -63.2% | 0.00% | -50.0% |
| Q1 2019 | $18,000 | +100.0% | 353 | -28.1% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | -43.8% | 491 | -9.9% | 0.00% | -42.9% |
| Q3 2018 | $16,000 | -11.1% | 545 | +5.8% | 0.01% | -12.5% |
| Q2 2018 | $18,000 | -5.3% | 515 | -13.2% | 0.01% | 0.0% |
| Q1 2018 | $19,000 | +18.8% | 593 | +0.7% | 0.01% | +33.3% |
| Q4 2017 | $16,000 | -44.8% | 589 | -26.1% | 0.01% | -62.5% |
| Q3 2017 | $29,000 | -3.3% | 797 | -1.7% | 0.02% | -5.9% |
| Q2 2017 | $30,000 | 0.0% | 811 | +29.1% | 0.02% | 0.0% |
| Q1 2017 | $30,000 | +87.5% | 628 | +31.7% | 0.02% | +88.9% |
| Q4 2016 | $16,000 | -27.3% | 477 | -19.6% | 0.01% | -30.8% |
| Q3 2016 | $22,000 | +29.4% | 593 | +16.5% | 0.01% | +30.0% |
| Q2 2016 | $17,000 | +13.3% | 509 | +3.2% | 0.01% | +11.1% |
| Q1 2016 | $15,000 | -57.1% | 493 | -48.5% | 0.01% | -59.1% |
| Q4 2015 | $35,000 | – | 958 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |